Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

18,214 total articles

Foremost Clean Energy Closes Bought Deal Private Placement for Aggregate Gross Proceeds of C$5.7 Million

Foremost Clean Energy Closes Bought Deal Private Placement for Aggregate Gross Proceeds of C$5.7 Million

Foremost Clean Energy Ltd. completed a bought deal private placement raising aggregate gross proceeds of C$5.7 million by issuing flow-through units to support exploration of its uranium and lithium properties in Canada. The capital will be used to incur qualifying Canadian exploration expenses on the company's mineral properties in Saskatchewan an…

Cadrenal Therapeutics Reports Fourth Quarter 2025 Financial Results; Provides Corporate Update on CAD-1005 Program for HIT Following End-of-Phase 2 FDA Meeting

Cadrenal Therapeutics Reports Fourth Quarter 2025 Financial Results; Provides Corporate Update on CAD-1005 Program for HIT Following End-of-Phase 2 FDA Meeting

Cadrenal Therapeutics reported strong fourth quarter and full-year 2025 results, highlighted by positive Phase 2 clinical data for its lead drug CAD-1005 treating heparin-induced thrombocytopenia (HIT). The company completed an End-of-Phase 2 meeting with the FDA, clarifying the regulatory strategy for its Phase 3 pivotal trial. CAD-1005 showed a s…

Pelthos Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of CT2000 in Eye Pain

Pelthos Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of CT2000 in Eye Pain

Pelthos Therapeutics announced the dosing of the first patient in a Phase 1b/2a clinical trial evaluating CT2000, an investigational NaV1.7 inhibitor eye drop formulation, as a treatment for acute and chronic ocular pain associated with dry eye disease. The trial will assess safety and efficacy with results expected by the end of 2026. Positive pre…

Dycom Industries, Inc. Appoints Company Veteran Bo Gresham as its First Chief Revenue Officer to Lead Next Phase of Growth

Dycom Industries, Inc. Appoints Company Veteran Bo Gresham as its First Chief Revenue Officer to Lead Next Phase of Growth

Dycom Industries appoints industry veteran Bo Gresham as its first Chief Revenue Officer to lead revenue growth and strategic market expansion amid a multi-year boom in digital infrastructure and fiber deployments. With nearly 30 years of experience, Gresham's promotion reflects Dycom's commitment to internal talent development and positions the co…

Micron Announces the Pricing of the Cash Tender Offers for Any and All of Certain Outstanding Senior Notes

Micron Announces the Pricing of the Cash Tender Offers for Any and All of Certain Outstanding Senior Notes

Micron Technology announced the pricing and terms for cash tender offers to repurchase various series of its outstanding senior notes, totaling several billion dollars. The offers include specific reference yields and notes considerations, with an expiration date of March 31, 2026, and expected settlement on April 3, 2026. The company emphasizes th…

New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional Facilities

New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional Facilities

Indivior Pharmaceuticals released a new cost impact model showing that their extended-release monthly injectable buprenorphine, SUBLOCADE®, could significantly reduce staff time and related costs in jails and prisons compared to other opioid use disorder medications. The model suggests reduced staffing needs and operational costs, potentially enhan…

Avalon Quantum AI Announces Strategic Collaboration with Caylent, an Amazon Web Services Premier Tier Partner, to Advance its Catch-Up Product into a Fully Autonomous Agentic AI Video Platform

Avalon Quantum AI Announces Strategic Collaboration with Caylent, an Amazon Web Services Premier Tier Partner, to Advance its Catch-Up Product into a Fully Autonomous Agentic AI Video Platform

Avalon GloboCare Corp., through its subsidiary Avalon Quantum AI LLC, has partnered with Caylent, an AWS Premier Tier Consulting Partner, to develop phase 2 of its Catch-Up AI video platform. The platform aims to evolve from a manually configured AI video system into a fully autonomous agentic AI video content creation and distribution solution tar…

Best Choice Roofing Surpasses One Billion Shingles Installed, Accelerates National Growth with ServiceTitan

Best Choice Roofing Surpasses One Billion Shingles Installed, Accelerates National Growth with ServiceTitan

ServiceTitan announced its ongoing technology partnership with Best Choice Roofing, which has surpassed one billion shingles installed. Best Choice Roofing is leveraging ServiceTitan's platform to standardize operations, enhance efficiency, and support nationwide expansion across over 80 locations. The partnership underpins Best Choice’s commitment…

SCYNEXIS Announces $40.0 Million Private Placement

SCYNEXIS Announces $40.0 Million Private Placement

SCYNEXIS, a biotechnology company developing therapies for severe rare diseases, announced a private placement expected to raise $40 million upfront, with the potential additional $52.2 million from warrant exercises pending shareholder approval. The proceeds are intended to fund general corporate purposes and extend operational runway into mid-202…

Le Mans Ultimate Releases Version 1.3 Update, Introducing Circuit de Barcelona-Catalunya, Duqueine D09 LMP3 Race Car, New Track Layouts, Logitech Trueforce Support and Performance Improvements

Le Mans Ultimate Releases Version 1.3 Update, Introducing Circuit de Barcelona-Catalunya, Duqueine D09 LMP3 Race Car, New Track Layouts, Logitech Trueforce Support and Performance Improvements

Motorsport Games released version 1.3 update for Le Mans Ultimate featuring the final European Le Mans Series Season Pass pack including the Duqueine D09 LMP3 race car, Circuit de Barcelona-Catalunya, new track layouts, Logitech Trueforce and haptic feedback integration, and performance optimizations. The update enhances realism and gameplay experi…

SCYNEXIS Completes Transformative Acquisition of PXL-770, an innovative, highly selective, direct AMPK activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

SCYNEXIS Completes Transformative Acquisition of PXL-770, an innovative, highly selective, direct AMPK activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

SCYNEXIS, Inc. completed the acquisition of PXL-770 (now SCY-770), a novel AMPK activator targeting Autosomal Dominant Polycystic Kidney Disease (ADPKD). This oral therapy has shown promising safety and efficacy in prior trials and is expected to enter Phase 2 proof-of-concept trials in Q4 2026 with early readouts in 2027. The acquisition strengthe…

USBC Regains Full NYSE American Compliance

USBC Regains Full NYSE American Compliance

USBC, Inc., a technology company specializing in tokenized deposit solutions, announced that it has regained full compliance with NYSE American listing standards as of March 27, 2026. This achievement follows a capital infusion linked to a controlling interest acquisition by the CEO's affiliate. The company is focused on launching its tokenized dep…

Progress Software Delivers Sitefinity Generative CMS for AI-Driven Discovery and Conversational Experiences

Progress Software Delivers Sitefinity Generative CMS for AI-Driven Discovery and Conversational Experiences

Progress Software announced an updated release of its Sitefinity Generative CMS that integrates generative AI to deliver personalized, AI-driven search, conversational interactions, and content delivery for enterprises. The platform emphasizes governance, brand consistency, and compliance while enabling scalable AI-powered digital experiences utili…

Allied Gold Reports Record Q4 Production, Advances Growth Strategy and Completes Key Step Toward Transaction with Zijin Gold

Allied Gold Reports Record Q4 Production, Advances Growth Strategy and Completes Key Step Toward Transaction with Zijin Gold

Allied Gold Corporation exceeded its 2025 production guidance with a record Q4 output of 117,004 ounces and total annual production of 379,081 ounces, driven by operational improvements at its mines. The company advanced key growth projects, including the Sadiola Phase 1 expansion and the Kurmuk Project, which is on schedule for mid-2026 production…

Ernexa Therapeutics Highlights Key Catalysts as Company Advances Toward First-in-Human Clinical Trials in 2026

Ernexa Therapeutics Highlights Key Catalysts as Company Advances Toward First-in-Human Clinical Trials in 2026

Ernexa Therapeutics, a US-based biotech company, announced its progress toward clinical development of ERNA-101, an engineered cell therapy designed to treat platinum-resistant ovarian cancer. The company plans to submit an IND application in Q3 2026 and initiate the first-in-human Phase 1 study in Q4 2026. Preclinical results showed promising dura…

LPL Financial Welcomes Five Star Wealth Planning

LPL Financial Welcomes Five Star Wealth Planning

LPL Financial announced that Tasha Coleman, founder of Five Star Wealth Planning, joined its platform along with her team, bringing approximately $185 million in assets. The move enhances LPL's advisor community, leveraging superior technology, AI capabilities, and cybersecurity to support multigenerational client relationships and long-term retire…

HCW Biologics Reports Fourth Quarter 2025 and Fiscal Year 2025 Business Highlights and Financial Results

HCW Biologics Reports Fourth Quarter 2025 and Fiscal Year 2025 Business Highlights and Financial Results

HCW Biologics Inc. announced its financial results for Q4 and FY 2025 highlighting the initiation of the Phase 1 clinical trial for HCW9302, a novel IL-2 fusion immunotherapeutic targeting autoimmune diseases like alopecia areata. The company secured $3.5 million upfront licensing fee from Beijing Trimmune Biotech for a preclinical molecule, expand…